Improving Therapeutic Learning for PTSD

Recruiting Phase 2 Interventional Study
PTSD Post Traumatic Stress Disorder
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 50
Sex
Female
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
120 (estimated)
Sponsor
University of Wisconsin, Madison · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The proposed project seeks to demonstrate the engagement of post-exposure dopamine neurotransmission and downstream acute reorganization of dopaminergic resting-state neural networks as a means of increasing consolidation of extinction memories formed during analogue exposure therapy in adult women with PTSD. Participants will include 120 women aged 21-50 with a current diagnosis of PTSD related t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Current diagnosis of PTSD where the index traumatic event includes physical or sexual assault * English speaking * Medically healthy Exclusion Criteria: * internal ferromagnetic objects (such as electronic devices, surgical implants, shrapnel, etc.) * major medical disorders…
Contacts

Rachel Williams

608-262-6375

rmwilliams5@wisc.edu

CONTACT